Drug
Tofogliflozin clinical trials
Also written CSG452.
- studies test it
- 6
- open now
- 1
- in phase 3
- 0
- first study started
- 2015
Keep track of what changes. Save the tofogliflozin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
6 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2015 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 2
- Phase 4
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 2
Kowa Research Institute, Inc. (3) · Kanazawa University (1) · Kowa Company, Ltd. (1) · Shinshu University (1)
Often tested with
Tested in the same studies.
K-877 (2) · Peptidoglycan Complex of Spirulina K-001 (1) · Glimepiride (1) · GLP-1 Mimetic (1) · Pemafibrate (1)
Studies
Open first, then newest update. How each study uses tofogliflozin is read from its arms, and is right about nine times in ten.
Testing it · 6
- Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD)RecruitingPhase 2Shinshu UniversityNCT05469659Written as Tofogliflozin
- Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver FibrosisCompletedPhase 2Kowa Research Institute, Inc.NCT05327127Written as CSG452
- Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452CompletedPhase 1Kowa Research Institute, Inc.NCT05722262Written as CSG452
- SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLDCompletedPhase 4Kanazawa UniversityNCT02649465Written as Tofogliflozin
- Tofogliflozin GLP-1 Analogue Combination TrialCompletedPhase 4Kowa Company, Ltd.NCT02537834Written as Tofogliflozin
- Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult VolunteersCompletedPhase 1Kowa Research Institute, Inc.NCT04237597Written as CSG452
Given in every arm · 1 — tofogliflozin is usual care beside what is tested
Codes
What other systems call tofogliflozin · ClinicalTrials.gg INT006144
- MeSH (NLM) C5750866-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triolConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) P8DD8KX4O4TOFOGLIFLOZINConfirmed FDA, NLM, Wikidata
- Wikidata Q15410175tofogliflozin hydrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152675TofogliflozinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C575086 | 6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | P8DD8KX4O4 | TOFOGLIFLOZIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q15410175 | tofogliflozin hydrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152675 | Tofogliflozin | One source FDA |
Also registered as tofogliflozin anhydrous (UNII 554245W62T).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.